A six-item short-form survey for measuring headache impact: the HIT-6.
M Kosinski, M S Bayliss, J B Bjorner...
https://pubmed.ncbi.nlm.nih.gov/14651415/Actively Recruiting
Led by The University of Texas Health Science Center at San Antonio · Updated on 2026-09-22
525
Participants Needed
8
Research Sites
47 weeks
Total Duration
Researchers are investigating treatments for chronic posttraumatic headache PTH in military service members and veterans who have experienced traumatic brain injury TBI. The study compares the effects of Clinic-based Cognitive Behavioral Therapy CCBT, Telemedicine-based Cognitive Behavioral Therapy TCBT, and treatment as usual TAU in reducing headache-related disability. This trial aims to confirm whether telemedicine delivery of CBT is as effective as in-person therapy and to replicate previous findings across multiple sites. Participants will be randomly assigned to one of three groups CCBT, which involves 8 weekly face-to-face sessions TCBT, which provides 8 weekly CBT sessions via telemedicine with additional procedures for safety and technical support or TAU, where participants continue their usual medical care for 8 weeks. The study is conducted at several VA medical centers and military treatment facilities across the U.S., with some sites limiting randomization to TCBT and TAU. During the study, participants will be assessed multiple times for headache-related disability using the Headache Impact Test HIT-6, headache experience, and mental health conditions such as depression, anxiety, and PTSD. Safety and adverse events are monitored, especially in the TAU group. The total timeline includes baseline, 3-month follow-up, and ongoing monitoring to evaluate treatment outcomes and patient perspectives on therapy experience.
CONDITIONS
Multisite Advancement of Research on Chronic Posttraumatic Headache
N
Nicole A Brackins, MS
F
Fermin A Carrizales
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The University of Texas Health Science Center at San Antonio
Lead Sponsor
Brooke Army Medical Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Clinic CBT | Telemedicine CBT | Treatment As Usual (TAU) |
|---|---|---|---|
| What is it? | Clinic-based CBT consists of 8 weekly in-person sessions of cognitive behavioral therapy designed to address posttraumatic headache after mild or moderate traumatic brain injury. | Telemedicine CBT consists of 8 weekly sessions delivered remotely, using video or telephone, with the same structure as clinic-based therapy for posttraumatic headache. | Treatment as usual involves continuing routine medical care without additional structured behavioral therapy sessions provided by the study. |
| Main purpose or use | To reduce headache frequency and disability using face-to-face cognitive behavioral therapy methods. | To deliver headache-focused CBT through remote sessions, increasing access to evidence-based care. | To provide standard medical management for posttraumatic headache, which may include medications and clinician follow-up. |
| How is it given or performed? | Participants attend eight weekly in-person sessions with a trained therapist, each lasting 45 to 75 minutes. | Participants connect for eight weekly therapy sessions remotely via phone or video call, each session lasting 45 to 75 minutes. | Participants continue their regular clinical care and medical follow-up as determined by their usual providers; no structured study therapy is provided. |
| Evidence status | Previous small studies and a systematic review suggest clinic-based CBT may help reduce headaches in people with posttraumatic headache, but further evidence is needed. | Telemedicine CBT is promising for pain and headache management, but robust evidence specific to posttraumatic headache is limited; its effectiveness is still being investigated. | Treatment as usual reflects typical medical management, but its effectiveness for posttraumatic headache varies and symptoms often persist. |
| Important limitations | Clinic-based CBT requires in-person attendance, which may limit accessibility for some participants. Evidence for its effectiveness in posttraumatic headache remains modest. | Requires reliable internet or telephone access and technological comfort, and long-term outcomes for telemedicine delivery in this population are not yet established. | Treatment as usual may not systematically address psychological contributors to posttraumatic headache, and some individuals continue to experience significant symptoms. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 8 weeks
Participants receive 8 weekly sessions of cognitive behavioral therapy either in a clinic or through telemedicine, or continue their usual medical care during this 8-week period.
Weekly therapy sessions or weekly calls for usual care group
Duration - Up to 3 months post-treatment
Participants are assessed at 3 months after baseline for headache-related disability, headache experience, and psychiatric symptoms to evaluate treatment effects.
1 to 2 follow-up visits or assessments
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
M Kosinski, M S Bayliss, J B Bjorner...
https://pubmed.ncbi.nlm.nih.gov/14651415/Kurt Kroenke, Robert L Spitzer, Janet B W Williams...
https://pubmed.ncbi.nlm.nih.gov/20633738/Brett J Theeler, Frederick G Flynn, Jay C Erickson
https://pubmed.ncbi.nlm.nih.gov/20553333/T J Schwedt, D W Dodick, J Hentz...
https://pubmed.ncbi.nlm.nih.gov/17257236/Louise S Roper, Peter Nightingale, Zhangjie Su...
https://pubmed.ncbi.nlm.nih.gov/28860853/Matthew D Holtkamp, Jamie Grimes, Geoffrey Ling
https://pubmed.ncbi.nlm.nih.gov/27084376/Mariana C Arcaya, Sarah R Lowe, Asad L Asad...
https://pubmed.ncbi.nlm.nih.gov/27929328/Donald D McGeary, Cindy A McGeary, Robert J Gatchel
https://pubmed.ncbi.nlm.nih.gov/22303839/Ajal Dave, Aravind Ganesh, Malik Muhammad Adil...
https://pubmed.ncbi.nlm.nih.gov/31341715/Donald D McGeary, Donald B Penzien, Patricia A Resick...
https://pubmed.ncbi.nlm.nih.gov/33490706/The University of Texas Health Science Center at San Antonio
Lead Sponsor
Brooke Army Medical Center
Collaborating Sponsor